Amandeep Rakhra, DO
Rheumatology · Omaha, NENPI 1720430184
Payments from drug & device makers
Across 472 payments — averaging $25.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Amgen$2K
- AbbVie$2K
- AstraZeneca$746
- UCB, Inc.$580
- Janssen Scientific Affairs, LLC$535
- plus $3K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 34 | $2,645 |
| Amgen | 118 | $2,423 |
| AbbVie | 76 | $1,849 |
| AstraZeneca(2 entities) | 27 | $746 |
| UCB, Inc. | 55 | $580 |
| Janssen Scientific Affairs, LLC | 7 | $535 |
| Aurinia Pharma U.S., Inc. | 17 | $534 |
| ANI Pharmaceuticals, Inc. | 28 | $507 |
| Lilly USA, LLC | 30 | $497 |
| GSK | 13 | $206 |
| Pfizer | 9 | $145 |
| Boehringer Ingelheim | 6 | $139 |
| Aimmune Therapeutics, Inc. | 1 | $130 |
| Sanofi | 2 | $130 |
| Mallinckrodt Hospital Products Inc. | 4 | $122 |
| Genentech USA, Inc. | 5 | $110 |
| Novo Nordisk | 6 | $106 |
| Bayer | 5 | $80 |
| Sandoz | 4 | $65 |
| Novartis | 3 | $52 |
| Radius Health, Inc. | 2 | $48 |
| Tonix Medicines, Inc. | 1 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Grifols USA, LLC | 1 | $29 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $28 |
| Kyowa Kirin, Inc. | 2 | $28 |
| Sobi, Inc | 2 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 2 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Corcept Therapeutics | 1 | $13 |
| Organon | 1 | $13 |
How this compares
$12,011 in reported general payments places this provider in the 75th percentile of 39 rheumatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Omaha
- William PalmerOmaha$534K
- Ted MikulsOmaha$433K
- Abhijeet DanveOmaha$118K
- Michael FeelyOmaha$93K
- Jay KenikOmaha$69K
- Lynell KlassenOmaha$68K
- Carolyn CoyleOmaha$6K
- Joseph NahasOmaha$6K
- James OdellOmaha$4K
- Kathryn WildyOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.